990x120 oct 6

Event Overview

Exaggerated immune responses contribute to COVID-19 pathogenesis. However, the specific cellular mediators and inflammatory components driving diverse clinical disease outcomes remain poorly understood. In this webinar sponsored by Advanced Cell Diagnostics (ACD), Madhvi Menon will describe the longitudinal immune profiling of hospitalized patients during the peak of the COVID-19 pandemic in the UK and the key immune signatures that associate with disease severity. Additionally, Jyoti Phatak-Sheldon will describe what researchers can learn about COVID-19 using ACD’s RNAscope in situ hybridization technology with RNA probes specific for SARS-CoV-2.

Topics to be covered
  • Immune profiling of COVID-19 patients in the UK
  • Immune signatures associated with severe COVID-19
  • Changes in immune signatures after recovery
  • RNAscope in situ hybridization technology specific for SARS-CoV-2
Tuesday, October 6, 2020
 
 2:30 - 4:00 PM, Eastern Standard Time


Speakers

Menon.png
Madhvi Menon, PhD
Presidential Research Fellow
School of Biological Sciences
University of Manchester

Phatak.png
Jyoti Phatak-Sheldon
Associate Scientist, Applications
Advanced Cell Diagnostics, a Bio-Techne Brand


ACD.png

Register Now

Longitudinal Immune Profiling Reveals Key Immune Signatures Associated with COVID-19

You must have Javascript and Cookies enabled to access this webcast.

Information you provide will be held in confidence and will be shared with the sponsoring vendor(s) of this webinar. We may use the information to contact you about your account and to let you know about related programs and products; you may opt-out at any time. This allows The Scientist to keep these webinars free of charge for our readers.